TTK Healthcare Ltd banner
T

TTK Healthcare Ltd
BSE:507747

Watchlist Manager
TTK Healthcare Ltd
BSE:507747
Watchlist
Price: 890.65 INR 1.9% Market Closed
Market Cap: ₹12.6B

Multiples-Based Value

The Multiples-Based Value of one TTKHEALTH stock under the Base Case scenario is hidden INR. Compared to the current market price of 890.65 INR, TTK Healthcare Ltd is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TTKHEALTH Multiples-Based Value
LOCKED
Unlock
Worst Case
Base Case
Best Case

Multiples Across Competitors

TTKHEALTH Competitors Multiples
TTK Healthcare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
TTK Healthcare Ltd
BSE:507747
12.5B INR 1.5 20.1 11.2 16.5
US
Eli Lilly and Co
NYSE:LLY
855.1B USD 13.2 41.6 28.1 30
US
Johnson & Johnson
NYSE:JNJ
574.7B USD 5.9 26.9 17.2 22
CH
Roche Holding AG
SIX:ROG
248.4B CHF 4.1 19.6 11.6 13.1
UK
AstraZeneca PLC
LSE:AZN
229B GBP 5.2 29.8 16.4 23.2
CH
Novartis AG
SIX:NOVN
228.1B CHF 5 20.2 12.5 16.1
US
Merck & Co Inc
NYSE:MRK
291.8B USD 4.4 15.8 9.8 11.9
IE
Endo International PLC
LSE:0Y5F
244.4B USD 105.4 -83.6 386.8 970
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.7 11.1 8.2 9.6
US
Pfizer Inc
NYSE:PFE
154.6B USD 2.5 19.9 7.7 10.2
UK
GlaxoSmithKline PLC
LSE:GSK
86.8B GBP 2.6 15.1 8.2 10.2
P/E Multiple
Earnings Growth PEG
IN
T
TTK Healthcare Ltd
BSE:507747
Average P/E: 22
20.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
41.6
31%
1.3
US
Johnson & Johnson
NYSE:JNJ
26.9
8%
3.4
CH
Roche Holding AG
SIX:ROG
19.6
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
29.8
25%
1.2
CH
Novartis AG
SIX:NOVN
20.2
14%
1.4
US
Merck & Co Inc
NYSE:MRK
15.8
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.1
0%
N/A
US
Pfizer Inc
NYSE:PFE
19.9
22%
0.9
UK
GlaxoSmithKline PLC
LSE:GSK
15.1
14%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
T
TTK Healthcare Ltd
BSE:507747
Average EV/EBITDA: 47.1
11.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
28.1
21%
1.3
US
Johnson & Johnson
NYSE:JNJ
17.2
8%
2.2
CH
Roche Holding AG
SIX:ROG
11.6
6%
1.9
UK
AstraZeneca PLC
LSE:AZN
16.4
12%
1.4
CH
Novartis AG
SIX:NOVN
12.5
5%
2.5
US
Merck & Co Inc
NYSE:MRK
9.8
4%
2.5
IE
E
Endo International PLC
LSE:0Y5F
386.8
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.2
2%
4.1
US
Pfizer Inc
NYSE:PFE
7.7
-8%
N/A
UK
GlaxoSmithKline PLC
LSE:GSK
8.2
3%
2.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
T
TTK Healthcare Ltd
BSE:507747
Average EV/EBIT: 103
16.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
22
13%
1.7
CH
Roche Holding AG
SIX:ROG
13.1
6%
2.2
UK
AstraZeneca PLC
LSE:AZN
23.2
21%
1.1
CH
Novartis AG
SIX:NOVN
16.1
9%
1.8
US
Merck & Co Inc
NYSE:MRK
11.9
6%
2
IE
E
Endo International PLC
LSE:0Y5F
970
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
US
Pfizer Inc
NYSE:PFE
10.2
-4%
N/A
UK
GlaxoSmithKline PLC
LSE:GSK
10.2
5%
2
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett